Hong Kong is developing a rapid test for chikungunya fever that could detect the disease at an earlier stage, as part of the city’s efforts to harness technology to combat the public health risk.
Ricky Chiu Yin-to, founder and CEO of biotechnology company Phase Scientific, said on Monday that his team was working to develop a rapid blood test that could yield results in 10 to 15 minutes by finger pricking.
The test being developed in Hong Kong aims to detect the antigen, specific proteins on the…
